{"topic_id":"ade_cefpodoxime_adverse_events","category":"ade","context":"---\ntopic_id: ade_cefpodoxime\ncategory: ade\ntitle: \"FDA ADE reports for Cefpodoxime — total reports, species & reaction breakdown\"\nlang: en\nsource: \"openFDA animalandveterinary/event.json (FDA CVM adverse event reports), pulled 2026-07-22\"\nsource_file: pdf-raw/ade/ade_active_ingredients_2026-07-22_b6.json\ndate_parsed: 2026-07-22\ntokens_estimated: 200\nverification:\n  method: substring_match\n  claims: 15\n  passed: 15\n  date: 2026-07-22\n---\n\n# Cefpodoxime — FDA Animal & Veterinary Adverse Event (ADE) Reports\n\nSource: openFDA `animalandveterinary/event.json`, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Cefpodoxime is a veterinary active ingredient.\n\n## Total reports\nCefpodoxime: 4172\n\n## Reports by species (top entries)\n- Dog 3982\n- Cat 86\n- Human 6\n- Horse 1\n\n## Top reported reactions (VEDDRA terms, top entries)\n- Vomiting 727\n- Lethargy (see also Central nervous system depression in 'Neurological') 457\n- Anorexia 386\n- Diarrhoea 327\n- Lack of efficacy - NOS 310\n- Other abnormal test result NOS 259\n- Emesis 255\n- Elevated alanine aminotransferase (ALT) 254\n- Death by euthanasia 230\n- Seizure NOS 215\n\n\"Lack of efficacy\" terms denote product-performance reports, not adverse reactions.\n\nSource JSON: `pdf-raw/ade/ade_active_ingredients_2026-07-22_b6.json` (openFDA animalandveterinary/event.json, pulled 2026-07-22).\n","sources":[],"tokens_estimated":200,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}